logo

Chimerix, Inc. (CMRX)



Trade CMRX now with
  Date
  Headline
11/10/2022 9:05:37 AM Rubric Calls On Chimerix Board To Begin Winddown process And Conserve Cash
5/16/2022 6:49:11 AM Emergent BioSolutions To Acquire Chimerix's Exclusive Worldwide Rights To TEMBEXA
11/22/2021 4:43:12 PM Wedbush Is Lowering Chimerix, Inc. (CMRX) FY22 Rev. Estimate To 1.9 M From 11.0 M
11/22/2021 4:42:41 PM Wedbush Is Lowering Chimerix, Inc. (CMRX) FY22 Estimate To -1.09 From -0.99
11/22/2021 4:42:27 PM Wedbush Is Lowering Chimerix, Inc. (CMRX) Q4 22 Estimate To -0.22 From -0.12
11/22/2021 4:41:44 PM Wedbush Reiterates Chimerix, Inc. (CMRX) At Outperform With $14 Down From $15 Price Target
1/20/2021 8:57:35 PM Chimerix Prices Underwritten Public Offering Of 11.77 Mln Shares At $8.50/shr
12/28/2015 1:17:44 PM FBR Capital Markets Is Raising Chimerix, Inc. (CMRX) FY16 Estimate To -1.76 From -3.35
12/28/2015 1:17:24 PM FBR Capital Markets Is Raising Chimerix, Inc. (CMRX) Q4 16 Estimate To -0.19 From -0.89
12/28/2015 1:16:53 PM FBR Capital Markets Is Increasing Chimerix, Inc. (CMRX) Q3 16 Estimate To -0.33 From -0.85
12/28/2015 1:16:25 PM FBR Capital Markets Is Increasing Chimerix, Inc. (CMRX) Q2 16 Estimate To -0.54 From -0.83
12/28/2015 1:15:37 PM FBR Capital Markets Is Raising Chimerix, Inc. (CMRX) Q1 16 Estimate To -0.70 From -0.80
12/28/2015 1:14:27 PM FBR Capital Markets Lowers Chimerix, Inc. (CMRX) To Market Perform From Outperform With $14.00 Price Target